• 한국어병학회지
• /
• 제35권2호
• /
• pp.185-193
• /
• 2022

This study investigated carnival behavior in the nursery stage of Fenneropenaeus chinensis. In order to suppress the carnival behavior and improve the survival rate, it was examined whether there was a carnivalism inhibitory effect according to the rearing water of shrimp. In addition, their blood physiological changes were observed. As a result, in the experimental group with the size difference of F. chinensis, the survival rate was the highest in the biofloc technology (BFT) rearing water of olive flounder (75%), and in the experimental group without the size difference, the survival rate was the highest in the seawater experiment group (93%). In both experimental groups, rate of carnival behavior was observed to be low in the fed experimental group regardless of the size difference of F. chinensis. As a result of blood cell analysis of F. chinensis according to the rearing water, the percentage of granulocytes was the highest in the BFT rearing water of flounder (75%) and the lowest in the filtered seawater group (66%). The proportion of semi-granulocytes was the highest at 11% in the shrimp BFT rearing water, and the lowest at 7% in the filtered seawater. The proportion of hyalinocytes was highest in filtered seawater (27%) and lowest in flounder BFT rearing water (16%). These results suggest that carnival behavior and blood composition of F. chinensis may be different depending on the conditions of the rearing water in the nursery stage.

• 한국초지조사료학회지
• /
• 제9권2호
• /
• pp.82-87
• /
• 1989

A field experiment was carried out to determine the effects of 11 different application levels of nitrogen (N), phosphorous ($P_2O_5$) and potassium($K_2O$) fertilizer in late-autumn on the winter survival, early spring growth and dry matter(DM) yield, carbohydrate reserves (CHO-R) in stubble of grasses, and botanical composition in orchardgrass dominated existing pasture in Suwon from October, 1987 to May, 1988. Winter survival of grasses was high (ca. 90%) in all N-fertilized plots, regardless of $P_2O_5$ and $K_2O$ application, and those in zero-N and zero-NPK plots were low as 86.5% and 81.4%, respectively. Early spring growth was vigorous in N-fertilized plots. Heading rate at the fist harvest was 80-86% in all N plots, regardless of $P_2O_5$ and $K_2O$, while those in zero-N and zero-NPK plots were very low as 61% and 56%, respectively. The DM yield of first harvest was higher in the plots of N 35 kg(Site B) and N 70kg $ha^{-1}$ (Site A), regardless of $P_2O_5$ and $K_2O$ level, and those in zero-N and zero-NPK plots were very low (p < 0.05). But no significant difference of yield was observed between N 75 kg and N 105 kg. CHO-R in stubble and legumes were high in zero-N and zero-NPK plots, and low relationship was found between winter survival and CHO-R of grasses. Winter survival, early spring growth and DM yield were significantly influenced by N fertilizer. In this experiment, the optimum application level of N in late-autumn could be recommended in 35-70 kg $ha^{-1}$, and no beneficial effects were observed by $P_2O_5$ and $K_2O$ fertilizer.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권4호
• /
• pp.1603-1609
• /
• 2014

Background: The response to treatment and overall survival (OS) of patients with acute myeloid leukemia (AML) is variable, with a median ranging from 6 months to 11.5 years. TP53 is associated with old age, chemotherapy resistance, and worse OS. Using genetic sequencing, we set out to look at our own experience with AML, and hypothesized that both TP53 mutations and SNPs at codon 72 would mimic the literature by occurring in a minority of patients, and conferring a worse OS. Materials and Methods: We performed a pilot study of randomly selected, newly diagnosed AML patients at Mount Sinai Medical Center, diagnosed from 2005-2008 (n=10). TP53 PCR sequencing was performed using DNA from bone marrow smears. Analysis was accomplished using Mutation Surveyor software with confirmation of the variants using the COSMIC and dbSNP databases. Results: Fewer than half of the patients harbored TP53 mutations (40%). There was no significant difference in OS based on gender, AML history, risk-stratified karyotype, or TP53 mutation. There were possible trends toward improved survival among patients less than 60 (11 vs 4 months, p=0.09), Hispanics (8 vs 1 months, p=0.11), and those not harboring SNP P72R (8 vs 2 months, p=0.10). There was a significant improvement in survival among patients with better performance status (28 vs 4 months, p=0.01) and those who did not have a complex karyotype (8 vs 1 months, p=0.03). The most commonly observed TP53 mutation was a missense N310K (40%) and the most commonly observed SNP was P72R (100.0%). Conclusions: Our study confirms previous reports that poor PS and the presence of a complex karyotype are associated with a decreased OS. In our cohort, TP53 mutations were relatively common, occurring more frequently in male patients with an adverse karyotype. Although there was no significant difference in survival between TP53 mutated and un-mutated patients, there was a possible trend toward worse OS among patients with SNP P72R. Larger studies are needed to validate these findings.

• 한국어류학회지
• /
• 제29권1호
• /
• pp.13-21
• /
• 2017

본 연구는 능성어(Epinephelus septemfasciatus)를 해수 순환여과양식시스템(RAS)에 적용하는데 문제가 되는 암모니아의 농도 기준을 제시하기 위하여 96시간 동안 암모니아 노출에 따른 생존율 및 혈액학적 특성 변화를 조사하였다. 생존율 실험구의 암모니아 농도는 대조구, 0.35, 0.4, 0.5, 0.8 mg/L였으며, 96-h $LC_{50}$ 농도는 0.6 mg/L로 나타났다. 능성어 치어의 암모니아 96-h $LC_{50}$ 농도인 0.6 mg/L에서 0, 3, 6, 12, 24, 48, 72, 96시간 간격으로 12마리씩 혈액 샘플링을 하였다. 실험구의 암모니아 노출 시간이 경과할수록 혈장 코티졸, 글루코스, GOT 및 GPT 농도가 증가하는 경향을 보였다. 혈장 암모니아와 총 단백질은 암모니아 노출 12시간째까지는 증가하였고 이후로는 감소하였지만, 대조구와 비교하여 유의하게 높은 값을 나타내었다. 또한 혈장 전해질이온($Na^+$, $Cl^-$)과 삼투압은 감소하는 경향이 관찰되었다.

• 대한두경부종양학회지
• /
• 제27권1호
• /
• pp.47-53
• /
• 2011

Purpose : Concurrent chemoradiotherapy(CCRT) with 3 weekly cisplatin is the standard treatment of locally advanced head and neck cancer(HNC). The aim is to evaluate the efficacy and toxicities of low-dose weekly cisplatin-based CCRT, which was devised to reduce the toxicity of CCRT. Method : We retrospectively analyzed HNC patients who received low-dose weekly cisplatin-based CCRT between 2008 and 2010. Cisplatin 35mg/$m^2$ was weekly given to all patients during radiotherapy. The efficacy was evaluated by the degree of clinical response, treatment failure and survival. The toxicity was evaluated by hematologic toxicities and oral mucositis. Results : A total of 27 patients were analyzed and median age was 59(range 31-81). The ratio of administered dose of radiotherapy and cisplatin to planned dose were 0.98 and 0.93, respectively. Complete remission and partial remission were 73% and 23%, respectively. Treatment failure was observed in 8(30%) patients. 1-year survival rate and 1-year disease free survival rate were 82% and 59%, respectively. Overall survival and progression-free survival did not reach median time. Grade 3/4 anemia, neutropenia, thrombocytopenia and oral mucositis were observed in 11%, 19%, 7% and 32% of patients, respectively. In terms of administered cycles, however, only 1-3% of grade 3/4 hematologic toxicities occurred among total 190 cycles. Severe oral mucositis were statistically associated with old age(p=0.003). Treatment failure had no statistical relation with age, pathology, primary site and stage. Conclusion : Low-dose weekly cisplatin-based CCRT seemed to deliver enough dose of cisplatin and to show low drop-out rate and good efficacy with low hematologic toxicities.

• 환경생물
• /
• 제34권3호
• /
• pp.193-200
• /
• 2016

해산로티퍼 (Brachionus plicatilis)의 생존율 및 개체군 성장률을 사용하여 중금속 As, Cr 및 Pb에 대한 독성평가를 수행하였다. 중금속에 24시간 노출한 생존율은 As와 Cr의 30과 $150mg\;L^{-1}$ 농도에서 급격한 감소가 시작되어 농도의존적으로 감소하였으나, Pb에서는 영향이 나타나지 않았다. 중금 속에 72시간 노출한 개체군 성장률은 As, Cr 및 Pb의 5, 25 및 $50mg\;L^{-1}$ 농도에서 급격한 감소가 시작되어, 3종 중금속에서 모두 농도의존적으로 감소하는 경향을 보였다. As, Cr 및 Pb에 노출된 개체군 성장률의 $EC_{50}$ 값은 각각 12.98, 82.34 및 $110.14mg\;L^{-1}$이고 독성의 세기는 As>Cr>Pb로 생존율과 동일하였다. 또한 As, Cr 및 Pb에 대한 개체군 성장률의 NOEC는 각각 1, 12.5 및 $50mg\;L^{-1}$, LOEC는 각각 5, 25 및 $50mg\;L^{-1}$로 나타났다. 해양환경에서 각각의 LOEC 이상의 농도는 B. plicatilis에게 독성영향을 미칠 수 있는 농도로 판단되며, NOEC와 $EC_{50}$ 값은 WET test를 위한 혼합독성과 해양생태계 내 중금속독성에 대한 가이드라인으로 적절하게 활용될 수 있을 것이다.

• 대한두경부종양학회지
• /
• 제24권2호
• /
• pp.162-168
• /
• 2008

Purpose：To know the results after induction chemotherapy followed by curative radiation therapy for locally advanced hypopharyngeal cancer Methods and Materials：From August 1990 to December 2003, forty patients who were treated with induction chemotherapy and curative radiation therapy were analyzed retrospectively. Median age of patients was 60 years(range：40-78 years) and clinical stage was wholly stage 3 or 4. Induction chemotherapy used cisplatin with 5-FU or docetaxel, and its interval was 3 weeks. Irradiated radiation dose was 70 to 78Gy (median：70.8Gy). Results：Median follow-up time was 39.4 months(range：8-115 months). Treatment failures were observed in 52.5% patients, and main failure pattern was local recurrence in 16 patients. 3 and 5 year disease free survival were 52.6%, 48.2% respectively and values of overall survival were 60.0, 43.9% and median survival time was 44.7 months. Treatment response was only a prognostic factor for survival. Laryngeal preservation was observed in twenty-four(60.0%) patients. Conclusion：Initial primary tumor stage was a significant prognostic factor for laryngeal preservation, and response after radiation therapy was a prognostic factor for long-term survival after induction chemotherapy followed by curative radiation therapy for locally advanced hypopharyngeal cancer.

• Tuberculosis and Respiratory Diseases
• /
• 제42권4호
• /
• pp.502-512
• /
• 1995

연구배경: 최근까지 국소 진행된 비소세포 폐암의 치료율을 높이려는 여러 노력들이 있어왔지만 향상은 보이지 않는 설정에서 최근의 유도 화학요법 및 다각적 병합요법의 치료결과와 본 병원의 예를 봄으로 반응률 및 치료 성적을 비교하고 생존에 영향을 미치는 제반 요소들과의 상호 관계에 대해 조사하여 보고하는 바이다. 방법: stage III로 진단된 비소세포 폐암환자 총 67 명을 각각의 치료별로 분류하여 화학치료만 받은 군은 A 군이라 칭하였고, 화학 치료및 방사선 치료를 받은 군은 B군, 수술과 화학 치료를 받은 군은 C군, 비 치료군으로는 D군으로 명하여 이들 군간의 반응률 및 치료 성적을 상호 비교하였고 생존에 영향을 미칠 여러 제반요소들과의 상관관계를 알아 보았다. 결과: 1) 화학 치료만 받은 군은 27 명, 화학 치료 및 방사선 치료를 같이 받은 군은 18 명, 수술 및 화학 치료를 받은 군은 15 명, 비 치료군은 7 명으로 각 군간의 나이, 운동능력, 혈액형, 조직학적, 성별, 흡연력의 분포에 있어서 차이가 없었다(p>0.05). 2) 화학 치료만 받은 군과 방사선 치료도 병합하여 받은 군의 총 반응률은 47%으로 A군의 경우가 10%, B군이 11%를 차지하였으며 이들 간에 의미있는 반응율의 차이는 없었다(p=0.97). 3) 나이, 성별, 운동능력, 혈액형, 조직학적 차이, 흡연력의 치아가 반응률에 영향을 미치지는 않았다(p>0.05). 4) 치료별 A, B, C, D 각 군에 따론 생존 기간은 8.6개월, 13.4개월, 19.2개월, 5.4 개월로 의미있는 차이를 보였다(p=0.003). 비치료군보다는 치료군이, 화학 치료로 단독 치료만 받은 군보다는 병합 치료를 받은 군이 오랜 생존 기간을 보였다. 5) 치료시 생존기간에 영향을 미칠 요소라는 운동능력과 진단 당시 임상병기로 나타났으나 그 외 나이, 성별, 혈액형, 조직학적 분류, 흡연력이 의미있는 차이를 가져오지는 않았다. 결론: 국소 진행된 비소세포 폐암환자에서 복합 화학요법을 포함하여 수술 및 방사선 치료와의 병행은 화학요법 단독으로 치료한 군이든지 혹을 비치료군에 비해 월등하게 생존 기간의 향상을 가져옴으로 좋은 적응증을 가진 환자들을 선택하여 효과적인 화학 치료 및 다른 치료법을 병행하여야 할 것으로 사료된다. 하지만 이러한 여러 치료법들이 표준 치료로 정립되기 위해서는 보다 충분한 증례에서 추후연구가 필요하리라 여겨지는 바이다.

• Journal of Korean Neurosurgical Society
• /
• 제30권4호
• /
• pp.430-436
• /
• 2001

Objective : The proliferative potential of intracranial glioma affects the histological malignancy and prognosis of patients with these tumors. In this study, we present the relationship between MIB-1 labeling index(LI) and clinical variables which might play the major role in determining the prognosis of patient with astrocytic tumors. Patients and Methods : Excised tumor specimens from a total of 52 patients were stained to detect monoclonal MIB-1-Ki-67 antibody by avidin-biotin complex immunohistochemistry. The MIB-1 LI was evaluated with histological grades, demograpghic data, and survival time. The statistical significance of their correlation was analyzed by Pearson correlation test. Results : The 52 patients included 30 male patients and 22 female patients. The tumors according to the criteria of the World Health Organization(WHO) classification were verified as pleomorphic xanthoastrocytoma in one, pilocytic astrocytomas 4, astrocytomas 1, anaplastic astrocytomas 3, and glioblastomas 31. MIB-1 LI in astrocytic ttumors showed no correlation with age and gender. However, the patients under 10 years had the longest survival time, whereas short survival time was observed in the older patients. The mean MIB-1 LI of different tumor grades were as follows : pleomorphic xanthoastrocytoma, $4.40{\pm}0.00$ ; pilocytic astrocytoma, $4.53{\pm}3.09$ ; astrocytoma, $5.50{\pm}6.03$ ; anaplastic astrocytoma, $12.68{\pm}12.50$ ; Glioblastoma, $21.31{\pm}19.63$. Although the levels of MIB-1 LI were varied in individual tumors, the MIB-1 LI was increased in parallel with the histological grades. Glioblstomas showed significantly higher MIB-1 LI compared with that of anaplastic astrocytomas and low grade astrocytomas (p = 0.001). The mean survival time of entire group of patients was also well correlated with MIB-1 LI in astrocytic tumors(p = 0.015). Moreover, the mean survival time of the entire group of patients with Lis < 10 was $125.33{\pm}113.57weeks$, and the mean survival of those with $Lis{\geq}10$ was $60.71{\pm}62.58weeks$. This difference was also statistically significant(p = 0.004). Conclusion : The results of this study suggest that MIB-1 LI correlates with histological grades and might play a significant role in predicting the survival of patients with astrocytic tumors.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권3호
• /
• pp.1615-1621
• /
• 2013

Background: Matrix metalloproteinase 9 (MMP-9) is related to tumor invasion and metastasis. However, the role of MMP-9 expression in breast cancer survival remains controversial. The purpose of this study was to accomplish a more accurate estimation of the association between MMP-9 expression and survival results in breast cancer patients through meta-analysis. Methods: A meta-analysis of published studies investigating the effects of positive MMP-9 expression on both relapse free survival (RFS) and overall survival (OS) was performed. Relevant literature was confirmed by searching electronic databases including PubMed, Ovid, EMBASE and China National Knowledge Infrastructure (CNKI) before November 1, 2012. Individual hazard ratios (HRs) and 95% confidence intervals (CIs) were extracted and pooled HRs with 95% CIs were used to evaluate the strength of the association between positive MMP-9 expression and survival results of breast cancer patients. Funnel plot and Egger's regression tests were used to evaluate publication bias. Heterogeneity and sensitivity analysis was also conducted. All the work was completed using STATA. Results: A total of 2,344 patients from 15 evaluative studies were finally included. Pooled HRs and 95% CIs suggested that MMP-9 overexpression had an unfavorable impact on both OS (HR: 1.70, 95% CI: 1.41-2.04) and RFS (HR: 1.54, 95% CI: 1.17-2.01) in breast cancer patients. There was no significant heterogeneity observed in the studies reported for OS (P=0.360, $I^2$=8.8%), but not RFS (P=0.002, $I^2$=67%). Publication bias was absent among the studies both in OS and RFS cases (t=-0.54, P=0.605 and t=1.71, P=0.131, respectively). Omission of any single study had little effect on the combined risk estimates on sensitivity analysis. Conclusion: The results of this meta-analysis suggest that positive MMP-9 expression confers a higher risk of relapse and a worse survival in patients with breast cancer. Larger prospective studies are now needed to evaluate the clinical utility of MMP-9 expression.